{"title":"Diabetes UK Professional Conference 2025 Abstract Author Index","authors":"","doi":"10.1111/dme.15499","DOIUrl":"https://doi.org/10.1111/dme.15499","url":null,"abstract":"<p>Ämmälä, C - A43 & P07</p><p>Abbas, Z - A35 & P215</p><p>Abbott, J - P22</p><p>AbdelBari, H - P122*</p><p>Abdelkader, A - P218</p><p>Abdelmagid, MI - P201*</p><p>Abdul, N - P219*</p><p>Abdullah, A - P172</p><p>Abi Chahine, T - P152 & P154</p><p>Abiakam, N - A20 & P61</p><p>Aboobakar, HA - A45 & P52</p><p>Abraham, AA - A33, P228 & P247</p><p>Abu Ghazaleh, H - P276</p><p>Ackroyd, D - P267</p><p>Acreman, S - A46, P16 & P33</p><p>Adamson, C - P218</p><p>Adamson, KA - A31 & P112</p><p>Adeyileka-Tracz, B - A35 & P215</p><p>Adie, MA - P67 & P68</p><p>Adler, A - P291</p><p>Adriano, A - P325 & P327</p><p>Afi Leslie, K - A56* & P35*</p><p>Ahamed Sadiq, S - P125*</p><p>Ahmad, B - A23 & P49</p><p>Ahmad, E - P267</p><p>Ahmad, S - P114</p><p>Ahmed, MSO - P239*</p><p>Ahmed, S - P211 & P268</p><p>Aitken, RJ - P91*</p><p>Ajjan, R - P236 & P243</p><p>Akbar, SA - P140*</p><p>Akerman, I - A41 & P17</p><p>Alabraba, V - P190 & P317</p><p>Alam, U - A60 & P273</p><p>Alatawi, AA - P98*</p><p>Alayyan, G - P338</p><p>Alazawi, W - A30 & P54</p><p>Aldafas, R - P39</p><p>Alen, R - P20*</p><p>Alexandrou, E - P51</p><p>Alexiadou, K - P81</p><p>Alghadouri, D - P172</p><p>Ali, A - P82* & P110</p><p>Ali, SY - P67</p><p>Ali, U - P218*</p><p>Ali, YA - P67 & P68</p><p>Ali Baig, S - P228</p><p>Alistair Williams Antibody Facility - A47</p><p>Aljedi, F - P172</p><p>Aljohani, N - P305* & P276</p><p>Alkandari, J - P172</p><p>Alkhalifah, G - P172</p><p>Allan, M - P195</p><p>Allard, C - A66 & P47</p><p>Allardice, B - P197</p><p>Allen, M - P40</p><p>Allen, MJ - P245</p><p>Allen-Taylor, M - P328</p><p>Al-Mrabeh, AH - A23*, P15, P49* & P69</p><p>Alobaid, T - P237*</p><p>Alonso, R - A55 & P19</p><p>Alonso Soriano, C - A3</p><p>Alozairi, E - P172</p><p>Alsaeed, D - P172, P216* & P217*</p><p>Alsayed, S – P276</p><p>Al-Selwi, Y - P26</p><p>Altaghadom, E - P172</p><p>Alturkait, A - P172*</p><p>Amiel, S - P64 & P64</p><p>Amoh, P - P202*</p><p>Anderson, R - P88</p><p>Andrew, R - P34</p><p>Andrews, A - P120*</p><p>Andrews, R - A34, P41 & P127</p><p>Andrews, RC - P40, P181, P201, P245, P325 & P327</p><p>Angeles-Agdeppa, I - A23 & P49</p><p>Ansari, I - A12 & P296</p><p>Ansari, MH - P226*</p><p>Ansari, S - P81*</p><p>Anson, M - A60 & P273</p><p>Anthony, IR - P183 & P184</p><p>Anthony, L - P205</p><p>Anwar, MB - P144*</p><p>Aqeel, A - P322</p><p>Ardavani, A - P05, P05* & P39*</p><p>Arden, C - P06 & P11</p><p>Aris, M - A69 & P262</p><p>Ariyakunaphan, P - A25 & P83</p><p>Arni, AM - A22 & P70</p><p>Arregui-Fresneda, I - P147</p><p>Asaad, M - P276* & P305</p><p>Ashcroft, FM - P23 & P25</p><p>Ashford, M - P02</p><p>Ashraf, UA - P231</p><p>Ashton-Cleary, S - P249</p><p>Ashton-Cleary, S - P290</p><p>Ashwell, S - P216</p><p>Asimakopoulou, K - P189</p><p>Asong, M - A38 & P295</p><p>Ast, J - A43 & P07</p><p>Atherton, H - P313</p><p>Atkinson, R - P2","PeriodicalId":11251,"journal":{"name":"Diabetic Medicine","volume":"42 S1","pages":""},"PeriodicalIF":3.2,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dme.15499","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143489991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Anke Versluis, Anne Meike Boels, Maaike C G Huijden, Manon D Mijnsbergen, Guy E H M Rutten, Rimke C Vos
{"title":"Diabetes self-management education and support delivered by mobile health (mHealth) interventions for adults with type 2 diabetes-A systematic review and meta-analysis.","authors":"Anke Versluis, Anne Meike Boels, Maaike C G Huijden, Manon D Mijnsbergen, Guy E H M Rutten, Rimke C Vos","doi":"10.1111/dme.70002","DOIUrl":"https://doi.org/10.1111/dme.70002","url":null,"abstract":"<p><strong>Background: </strong>Diabetes self-management education (DSME) and support (DSME/S) delivered via mobile health (mHealth) is potentially cost-effective, if proven effective.</p><p><strong>Objectives: </strong>To assess the effectiveness of DSME, DSMS or DSME/S delivered by mHealth interventions compared to usual care (UC) or attention placebo control (APC) in adults with type 2 diabetes.</p><p><strong>Methods: </strong>We searched (1) MEDLINE, (2) Embase, (3) PsycINFO, (4) Cochrane Central Register of Controlled Trials via the Cochrane Register of Studies Online, (5) ClinicalTrials.gov, and (6) World Health Organization International Clinical Trials Registry Platform from the year 2000 to January 31, 2023. We included RCTs comparing DSME/S delivered via mHealth versus UC or APC. Four authors independently selected trials, assessed risk of bias and extracted data. Primary outcome was HbA1c, outher outcomes secundairy. Meta-analysed with random-effects model was used.</p><p><strong>Results: </strong>We included 43 trials involving 9328 participants; sample sizes ranging from 20 to 1119. Pooled effects on HbA1c were for DSME: mean difference (MD) of -4 mmol/mol (-0.3%), 95% CI -6 mmol/mol (-0.6%) to -1 mmol/mol (-0.1); p = 0.002; DSMS MD -4 mmol/mol (-0.4%), 95% CI 7 mmol/mol (-0.6%) to -2 mmol/mol (-0.2); p < 0.001; and DSME/S MD of -2 mmol/mol (-0.2%) for HbA1c, 95% CI -3 mmol/mol (-0.3%) to -0 mmol/mol (-0.0%); p < 0.001. We found uncertain effects on other outcomes.</p><p><strong>Conclusions: </strong>mHealth interventions delivering self management education with or without support to adults with type 2 diabetes appear to have a modest beneficial effect on HbA1c. Only a few trials investigated patient-reported outcomes.</p>","PeriodicalId":11251,"journal":{"name":"Diabetic Medicine","volume":" ","pages":"e70002"},"PeriodicalIF":3.2,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143499937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
E H Alkhatib, M Segawa, A Danner, H Kasper, E Frymark, S Roberts, L Clary, R Streisand, S Majidi
{"title":"Feasibility of a multidisciplinary pilot intervention for parent/caregiver diabetes distress.","authors":"E H Alkhatib, M Segawa, A Danner, H Kasper, E Frymark, S Roberts, L Clary, R Streisand, S Majidi","doi":"10.1111/dme.70006","DOIUrl":"https://doi.org/10.1111/dme.70006","url":null,"abstract":"<p><strong>Aims: </strong>Caregiver diabetes distress (DD) consists of negative emotions about a child's T1D diagnosis and has been associated with increased child haemoglobin A1c and family conflict. The primary aim was to identify the feasibility and acceptability of a multidisciplinary pilot intervention for caregiver DD in a diverse academic pediatric diabetes centre. Another primary aim was to determine the percentage of local caregivers with DD. A secondary aim was to determine if the intervention affected caregiver DD. We also explored potential associations between caregiver DD and demographic and diabetes-related characteristics.</p><p><strong>Methods: </strong>Individual interviews with five caregivers with DD (who did not participate in the intervention) were held pre-intervention, in order to gather qualitative, open-ended feedback on prepared educational materials. As a pilot feasibility study, we held 3 monthly, one-hour educational and support group virtual sessions per cohort (6-8 caregivers) on Nutrition, Fear of Hypoglycemia and Parent/Child Collaboration. Sessions were attended by an endocrinologist with leaders from other disciplines including dietician, diabetes educator and/or social worker. Target enrollment was 30 caregivers with DD (PAID-PR/Problem Areas in Diabetes-Parent Revised score of ≥56/100) of children 5-17 years old with T1D for ≥6 months. Data include demographic information, pre-/post- PAID-PR scores, caregivers' session satisfaction ratings and open-ended written feedback. We also examined data from 26 parents of children who did not have elevated scores on DD (the comparison group) and were not invited to attend the intervention sessions.</p><p><strong>Results: </strong>Caregiver participants were 85% women, ages 42.5 ± 11.3 years; children's characteristics: 38% girls, ages 11.1 ± 2.1 years, 47.6% Black, 33.3% Caucasian, 9.5% Hispanic, 9.6% other, 43% public insurance, mean diabetes duration 4.3 ± 0.18 years and A1c 8.5 ± 0.7% (69.4 mmol/mol). Pre- and post-intervention PAID-PR scores improved from 68 to 51 (p < 0.05). This was sustained 3 months post-intervention with a mean PAID-PR of 42 (p < 0.05).</p><p><strong>Conclusion: </strong>The pilot intervention was feasible, with two-thirds of caregivers attending ≥2 sessions. Reported DD improved over time. Limitations include a small initial sample. Future directions include expanding this study to a larger population and ultimately incorporating a similar support program into the clinical setting as part of routine outpatient diabetes care.</p>","PeriodicalId":11251,"journal":{"name":"Diabetic Medicine","volume":" ","pages":"e70006"},"PeriodicalIF":3.2,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143457237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lakshmi N Rengarajan, Catherine Cooper, Kashish Malhotra, Angelica Sharma, Nevil Philip, Anu Ann Abraham, Ketan Dhatariya, Parth Narendran, Punith Kempegowda
{"title":"DEKODE-A cloud-based performance feedback model improved DKA care across multiple hospitals in the UK.","authors":"Lakshmi N Rengarajan, Catherine Cooper, Kashish Malhotra, Angelica Sharma, Nevil Philip, Anu Ann Abraham, Ketan Dhatariya, Parth Narendran, Punith Kempegowda","doi":"10.1111/dme.70004","DOIUrl":"https://doi.org/10.1111/dme.70004","url":null,"abstract":"<p><strong>Aim: </strong>A current gap in Diabetes-related ketoacidosis (DKA) research is understanding the factors contributing to variations in care and outcomes between people admitted with DKA. We aimed to create a system to facilitate gathering data on DKA management across multiple centres and identify trends in complications and outcomes associated with DKA.</p><p><strong>Research design and methods: </strong>Between January 2020 and December 2022, we set up a cloud-based Quality improvement project (QIP) that provided regular feedback to 11 hospitals in the United Kingdom (UK).</p><p><strong>Results: </strong>Of the 1977 episodes, we observed an increase in adherence in fluid prescription in hospitals C, D, E, F and G (C- 23% vs. 75% p = <0.001; D- 27% vs. 60%, p = <0.001; E- 17 vs. 79% p = <0.001; F- 16% vs. 57%, p = <0.001; G- 36% vs. 75% p = <0.001). Notable improvements in adherence to glucose monitoring were observed in hospitals B, D, and G (B- 11 vs. 38% p = <0.001; D- 36% vs. 56%, p = 0.05; G- 22% vs. 67% p = <0.001). Although we didn't observe significant changes in complications and outcomes among participating hospitals from the start to the end of the reported period, notable fluctuations were evident across quarters. These variations were relayed to the respective hospitals, underscoring how feedback and interventions could influence the care provided. This initiative also marks the initial move towards establishing and improving data collection practices in acute diabetes.</p><p><strong>Conclusions: </strong>We demonstrate a sustainable QIP that improves adherence to national guidelines in some indicators for DKA care and serves as an early warning system to identify adverse trends.</p>","PeriodicalId":11251,"journal":{"name":"Diabetic Medicine","volume":" ","pages":"e70004"},"PeriodicalIF":3.2,"publicationDate":"2025-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143432441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Steven James, Jayanthi Maniam, Jessica Jones, Olive James, Chloe Tarlton, Judy Craft, Kim C Donaghue, Barnaby Dixson, Maria E Craig
{"title":"Travel health and people living with type 1 diabetes.","authors":"Steven James, Jayanthi Maniam, Jessica Jones, Olive James, Chloe Tarlton, Judy Craft, Kim C Donaghue, Barnaby Dixson, Maria E Craig","doi":"10.1111/dme.70012","DOIUrl":"https://doi.org/10.1111/dme.70012","url":null,"abstract":"","PeriodicalId":11251,"journal":{"name":"Diabetic Medicine","volume":" ","pages":"e70012"},"PeriodicalIF":3.2,"publicationDate":"2025-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143425178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Katie Fitzgerald, Christina Jones, Helen Partridge, Lindsey Rouse, Rose-Marie Satherley
{"title":"Exploring healthcare professionals' attitudes to screening for disordered eating in type 1 diabetes.","authors":"Katie Fitzgerald, Christina Jones, Helen Partridge, Lindsey Rouse, Rose-Marie Satherley","doi":"10.1111/dme.70003","DOIUrl":"https://doi.org/10.1111/dme.70003","url":null,"abstract":"<p><strong>Aims: </strong>Eating disorders and disordered eating behaviours are prevalent among adults with type 1 diabetes, making early identification essential for improving health outcomes. Although screening tools exist to detect disordered eating in type 1 diabetes (T1DE), their application in clinical practice remains limited. This study investigates healthcare professionals' perspectives and attitudes towards screening for disordered eating in adult diabetes services.</p><p><strong>Methodology: </strong>This qualitative study employed semi-structured interviews with 13 healthcare professionals from adult diabetes services. Purposive sampling was used to ensure a broad range of healthcare professional viewpoints. The interviews centred on their perceptions of screening for disordered eating in type 1 diabetes.</p><p><strong>Results: </strong>Reflexive thematic analysis was used to identify four themes: (1) Uncertainty and Inevitabiltiy of T1DE: 'A bit of a black hole', (2) Asking about T1DE: 'My fear is…am I overstepping the line', (3) Patient-provider relationships: 'A backward step', and (4) Lack of support for T1DE: 'Where do you go?'. While healthcare professionals recognised the link between diabetes management and disordered eating, they lacked confidence in screening for these challenges due to limited time and the scarcity of specialist disordered eating resources for type 1 diabetes.</p><p><strong>Conclusion: </strong>This study highlights the challenges healthcare professionals face in screening for disordered eating in type 1 diabetes. By highlighting the need for enhanced training and clear clinical guidelines, this research suggests pathways to improve healthcare professional confidence in addressing these critical conversations with patients, ultimately supporting better health outcomes.</p>","PeriodicalId":11251,"journal":{"name":"Diabetic Medicine","volume":" ","pages":"e70003"},"PeriodicalIF":3.2,"publicationDate":"2025-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143413781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Guidelines for the management of diabetes-related ketoacidosis (DKA) have been poorly adopted and implemented, resulting in a lack of improvement in outcomes.","authors":"Angelica Sharma, Lakshmi Rengarajan, Parth Narendran, Ketan Dhatariya, Punith Kempegowda","doi":"10.1111/dme.70010","DOIUrl":"https://doi.org/10.1111/dme.70010","url":null,"abstract":"<p><strong>Aims: </strong>The Joint British Diabetes Society-Inpatient (JBDS-IP) group recommends reducing fixed rate intravenous insulin infusion (FRIII) from 0.1 to 0.05 units/kg/h when blood glucose falls <14 mmol/L to reduce the risk of complications associated with acute management of diabetes-related ketoacidosis. However, whether this change results in real-world improvements is not known.</p><p><strong>Methods: </strong>We performed a retrospective review of DKA admissions between October 2021 and March 2023 across five hospitals in the United Kingdom. We collated data on demographics, biochemical profiles, management interventions, complications, and outcomes.</p><p><strong>Results: </strong>We identified 753 DKA admissions. There was a slow uptake of reduced-rate FRIII, reaching 49.7% over 18 months. In DKA episodes where FRIII rate reduction guidelines were adopted, there was a significant lag (median [IQR] hours) between starting 10% Dextrose and FRIII rate reduction when blood glucose became <14 mmol/L (0.5 (0.1-1.8) vs. 3.2 (0.7-6.5), p = 0.00001). There was no significant reduction in hypoglycaemia (16.5% vs. 13.8%, p = 0.344) in episodes that adopted FRIII reduction. There were no significant differences in the frequency of hypokalaemia, hyperkalaemia, DKA duration, and length of stay between episodes with FRIII rate reduction versus those without FRIII.</p><p><strong>Conclusions: </strong>Our study demonstrates suboptimal adoption of guidelines. Therefore, it was perhaps unsurprising that no favourable effect on the rate of complications or outcomes in DKA episodes with reduced-rate FRIII was demonstrated. In DKA episodes where FRIII rate reduction was adopted, there was a significant delay in adjusting the FRIII when glucose levels were <14 mmol/L. Understanding the barriers and facilitators is vital in creating resources to safely implement guidelines.</p>","PeriodicalId":11251,"journal":{"name":"Diabetic Medicine","volume":" ","pages":"e70010"},"PeriodicalIF":3.2,"publicationDate":"2025-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143390276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
